Blood Transfusion Diagnostics Market Size to Hit USD 8.79 Billion by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Blood Transfusion Diagnostics Market

5.1. COVID-19 Landscape: Blood Transfusion Diagnostics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Blood Transfusion Diagnostics Market, By Product Type

8.1. Blood Transfusion Diagnostics Market Revenue and Volume Forecast, by Product Type

8.1.1. Instruments

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Reagents & Kits

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Software & Services

8.1.3.1. Market Revenue and Volume Forecast

Chapter 9. Global Blood Transfusion Diagnostics Market, By Test Type

9.1. Blood Transfusion Diagnostics Market Revenue and Volume Forecast, by Test Type

9.1.1. Blood Group Typing

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Disease Screening

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Molecular Testing

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Crossmatching & Compatibility Testing

9.1.4.1. Market Revenue and Volume Forecast

Chapter 10. Global Blood Transfusion Diagnostics Market, By Technology

10.1. Blood Transfusion Diagnostics Market Revenue and Volume Forecast, by Technology

10.1.1. Serology-based Testing

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Molecular-based Testing

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Microarray

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Next-generation Sequencing (NGS)

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Enzyme-linked Immunosorbent Assay (ELISA)

10.1.5.1. Market Revenue and Volume Forecast

10.1.6. Rapid Diagnostics

10.1.6.1. Market Revenue and Volume Forecast

10.1.7. Others

10.1.7.1. Market Revenue and Volume Forecast

Chapter 11. Global Blood Transfusion Diagnostics Market, By End User

11.1. Blood Transfusion Diagnostics Market Revenue and Volume Forecast, by End User

11.1.1. Hospitals

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Blood Banks

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Diagnostic Laboratories

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Plasma Fractionation Centers

11.1.4.1. Market Revenue and Volume Forecast

11.1.5. Academic & Research Institutes

11.1.5.1. Market Revenue and Volume Forecast

11.1.6. Others

11.1.6.1. Market Revenue and Volume Forecast

Chapter 12. Global Blood Transfusion Diagnostics Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Product Type

12.1.2. Market Revenue and Volume Forecast, by Test Type

12.1.3. Market Revenue and Volume Forecast, by Technology

12.1.4. Market Revenue and Volume Forecast, by End User

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Product Type

12.1.5.2. Market Revenue and Volume Forecast, by Test Type

12.1.5.3. Market Revenue and Volume Forecast, by Technology

12.1.5.4. Market Revenue and Volume Forecast, by End User

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Product Type

12.1.6.2. Market Revenue and Volume Forecast, by Test Type

12.1.6.3. Market Revenue and Volume Forecast, by Technology

12.1.6.4. Market Revenue and Volume Forecast, by End User

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Product Type

12.2.2. Market Revenue and Volume Forecast, by Test Type

12.2.3. Market Revenue and Volume Forecast, by Technology

12.2.4. Market Revenue and Volume Forecast, by End User

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Product Type

12.2.5.2. Market Revenue and Volume Forecast, by Test Type

12.2.5.3. Market Revenue and Volume Forecast, by Technology

12.2.5.4. Market Revenue and Volume Forecast, by End User

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Product Type

12.2.6.2. Market Revenue and Volume Forecast, by Test Type

12.2.6.3. Market Revenue and Volume Forecast, by Technology

12.2.6.4. Market Revenue and Volume Forecast, by End User

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Product Type

12.2.7.2. Market Revenue and Volume Forecast, by Test Type

12.2.7.3. Market Revenue and Volume Forecast, by Technology

12.2.7.4. Market Revenue and Volume Forecast, by End User

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Product Type

12.2.8.2. Market Revenue and Volume Forecast, by Test Type

12.2.8.3. Market Revenue and Volume Forecast, by Technology

12.2.8.4. Market Revenue and Volume Forecast, by End User

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Product Type

12.3.2. Market Revenue and Volume Forecast, by Test Type

12.3.3. Market Revenue and Volume Forecast, by Technology

12.3.4. Market Revenue and Volume Forecast, by End User

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Product Type

12.3.5.2. Market Revenue and Volume Forecast, by Test Type

12.3.5.3. Market Revenue and Volume Forecast, by Technology

12.3.5.4. Market Revenue and Volume Forecast, by End User

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Product Type

12.3.6.2. Market Revenue and Volume Forecast, by Test Type

12.3.6.3. Market Revenue and Volume Forecast, by Technology

12.3.6.4. Market Revenue and Volume Forecast, by End User

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Product Type

12.3.7.2. Market Revenue and Volume Forecast, by Test Type

12.3.7.3. Market Revenue and Volume Forecast, by Technology

12.3.7.4. Market Revenue and Volume Forecast, by End User

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Product Type

12.3.8.2. Market Revenue and Volume Forecast, by Test Type

12.3.8.3. Market Revenue and Volume Forecast, by Technology

12.3.8.4. Market Revenue and Volume Forecast, by End User

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Product Type

12.4.2. Market Revenue and Volume Forecast, by Test Type

12.4.3. Market Revenue and Volume Forecast, by Technology

12.4.4. Market Revenue and Volume Forecast, by End User

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Product Type

12.4.5.2. Market Revenue and Volume Forecast, by Test Type

12.4.5.3. Market Revenue and Volume Forecast, by Technology

12.4.5.4. Market Revenue and Volume Forecast, by End User

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Product Type

12.4.6.2. Market Revenue and Volume Forecast, by Test Type

12.4.6.3. Market Revenue and Volume Forecast, by Technology

12.4.6.4. Market Revenue and Volume Forecast, by End User

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Product Type

12.4.7.2. Market Revenue and Volume Forecast, by Test Type

12.4.7.3. Market Revenue and Volume Forecast, by Technology

12.4.7.4. Market Revenue and Volume Forecast, by End User

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Product Type

12.4.8.2. Market Revenue and Volume Forecast, by Test Type

12.4.8.3. Market Revenue and Volume Forecast, by Technology

12.4.8.4. Market Revenue and Volume Forecast, by End User

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Product Type

12.5.2. Market Revenue and Volume Forecast, by Test Type

12.5.3. Market Revenue and Volume Forecast, by Technology

12.5.4. Market Revenue and Volume Forecast, by End User

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Product Type

12.5.5.2. Market Revenue and Volume Forecast, by Test Type

12.5.5.3. Market Revenue and Volume Forecast, by Technology

12.5.5.4. Market Revenue and Volume Forecast, by End User

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Product Type

12.5.6.2. Market Revenue and Volume Forecast, by Test Type

12.5.6.3. Market Revenue and Volume Forecast, by Technology

12.5.6.4. Market Revenue and Volume Forecast, by End User

Chapter 13. Company Profiles

13.1. Grifols, S.A.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial PerProduct Typeance

13.1.4. Recent Initiatives

13.2. Ortho Clinical Diagnostics

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial PerProduct Typeance

13.2.4. Recent Initiatives

13.3. Bio-Rad Laboratories, Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial PerProduct Typeance

13.3.4. Recent Initiatives

13.4. F. Hoffmann-La Roche Ltd.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial PerProduct Typeance

13.4.4. Recent Initiatives

13.5. Abbott Laboratories

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial PerProduct Typeance

13.5.4. Recent Initiatives

13.6. Siemens Healthineers AG

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial PerProduct Typeance

13.6.4. Recent Initiatives

13.7. Immucor, Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial PerProduct Typeance

13.7.4. Recent Initiatives

13.8. Thermo Fisher Scientific Inc.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial PerProduct Typeance

13.8.4. Recent Initiatives

13.9. Quotient Limited

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial PerProduct Typeance

13.9.4. Recent Initiatives

13.10. Danaher Corporation (Beckman Coulter)

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial PerProduct Typeance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The blood transfusion diagnostics market size is expected to increase from USD 4.98 billion in 2024 to USD 8.79 billion by 2034.

The blood transfusion diagnostics market is expected to grow at a compound annual growth rate (CAGR) of around 5.84% from 2025 to 2034.

The major players in the blood transfusion diagnostics market include Grifols, S.A., Ortho Clinical Diagnostics, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers AG, Immucor, Inc., Thermo Fisher Scientific Inc., Quotient Limited, Danaher Corporation (Beckman Coulter), Becton, Dickinson and Company (BD), HemoCue AB, BioMérieux SA, DiaSorin S.p.A., Sysmex Corporation, Bag Health Care GmbH, Fresenius Kabi AG, Gen-Probe Incorporated (Hologic), Agena Bioscience, Inc., and Tulip Diagnostics (P) Ltd.

The driving factors of the blood transfusion diagnostics market are the increasing number of chronic blood disorders and more blood transfusion procedures. Improvements in high-sensitivity screening methods, such as NAT, PCR, and AI, alongside global blood safety campaigns and better healthcare infrastructure, are contributing to market expansion.

North America region will lead the global blood transfusion diagnostics market during the forecast period 2025 to 2034.